LEXINGTON, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company ...

Voyager Therapeutics has hit pause on a preclinical Alzheimer’s disease program just eight months after unveiling the asset. The neurology biotech announced back in July 2025 that it was adding a new ...

Voyager Technologies, Inc. VOYG shares are trading higher Monday after the company announced it was awarded a ...

Voyager Technologies (NYSE: VOYG) was awarded a follow-on contract under NASA’s Expendable Launch Vehicle Integrated Support 3, or ELVIS 3, program through prime contractor a.i. solutions. The ...

Voyager Technologies (NYSE:VOYG) appointed Shoshanna Moody as Chief Administrative Officer. Moody is tasked with supporting operational scale and regulatory compliance as the company expands into ...